Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion type Assertion NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_head.
- NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion description "[AREG is preferentially expressed in breast tumors co-expressing HER2/HER4/is associated with estradiol receptors, small tumour size, low histoprognostic grading, high HER4 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_provenance.
- NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion evidence source_evidence_literature NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_provenance.
- NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion SIO_000772 17962208 NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_provenance.
- NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion wasDerivedFrom lhgdn-20090331 NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_provenance.
- NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_assertion wasGeneratedBy ECO_0000203 NP172825.RAuQq9NVqLIwzLZeTeVPj_pvTFxkN0fdPvaMakybC9R6A130_provenance.